Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Acq. announced
Appointed director

INSITE VISION INC (INSV) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/04/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
11/04/2015 4 TOOMAN CRAIG A (Director) has filed a Form 4 on INSITE VISION INC
11/04/2015 4 RUANE TIMOTHY M (CEO) has filed a Form 4 on INSITE VISION INC
11/04/2015 4 Patel Surendra (VP, Operations & Quality) has filed a Form 4 on INSITE VISION INC
11/04/2015 4 O'Holla Robert (Director) has filed a Form 4 on INSITE VISION INC
11/04/2015 4 MCINERNEY TIMOTHY (Director) has filed a Form 4 on INSITE VISION INC
Txns: Disposed/sold 30,000 options to buy @ $0.52, valued at $15.6k
Disposed/sold 150,000 options to buy @ $0.38, valued at $57k
Disposed/sold 150,000 options to buy @ $0.33, valued at $49.5k
Disposed/sold 150,000 options to buy @ $0.44, valued at $66k
Disposed/sold 150,000 options to buy @ $0.32, valued at $48k
Disposed/sold 150,000 options to buy @ $0.23, valued at $34.5k
Disposed/sold 150,000 options to buy @ $0.22, valued at $33k
Disposed/sold 66,666 warrants @ $0.75, valued at $50k
Disposed/sold 287,357 warrants @ $0.33, valued at $94.8k
Disposed/sold 362,319 warrants @ $0.26, valued at $94.2k
Disposed/sold 444,445 warrants @ $0.18, valued at $80k
11/04/2015 4 LEVY BRIAN (Director) has filed a Form 4 on INSITE VISION INC
11/04/2015 4 Hosseini Kamran (VP, Clinical Affairs & CMO) has filed a Form 4 on INSITE VISION INC
11/04/2015 4 DRAPEAU LOUIS (Vice President and CFO) has filed a Form 4 on INSITE VISION INC
11/04/2015 4 BOWMAN LYLE M JR (VP, Development) has filed a Form 4 on INSITE VISION INC
11/02/2015 8-K Quarterly results
10/30/2015 4 RUANE TIMOTHY M (CEO) has filed a Form 4 on INSITE VISION INC
10/30/2015 4 Patel Surendra (VP, Operations & Quality) has filed a Form 4 on INSITE VISION INC
10/30/2015 4 MCINERNEY TIMOTHY (Director) has filed a Form 4 on INSITE VISION INC
Txns: Unknown transaction of 600,786 shares @ $0.35, valued at $210.3k
10/30/2015 4 Hosseini Kamran (VP, Clinical Affairs & CMO) has filed a Form 4 on INSITE VISION INC
10/30/2015 4 DRAPEAU LOUIS (Vice President and CFO) has filed a Form 4 on INSITE VISION INC
10/30/2015 4 BOWMAN LYLE M JR (VP, Development) has filed a Form 4 on INSITE VISION INC
10/28/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/28/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/19/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/30/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
09/29/2015 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
09/29/2015 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
09/28/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
09/28/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amended and Restated Agreement and Plan of Merger, by and among the Company, Ranbaxy and Merger Sub, as amended and restated September 28, 2015"
09/28/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/15/2015 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
09/15/2015 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
09/15/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
09/15/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/15/2015 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
09/15/2015 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Agreement and Plan of Merger, by and among the Company, Ranbaxy and Merger Sub",
"Secured Note, by and between the Company and Ranbaxy",
"Security Agreement, by and between the Company and Ranbaxy",
"IP Security Agreement, by and between the Company and Ranbaxy",
"Form of Amendment, Waiver and Consent Agreement",
"InSite Vision and Sun Pharma Enter into Merger Agreement Shareholders Will Receive $0.35 per Share in Cash at Closing InSite Terminates Merger Agreement with QLT Inc."
09/15/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/15/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy